Novel TENM3–ALK fusion is an alternate mechanism for ALK activation in neuroblastoma-Reference-Cited by-同舟云学术

Novel TENM3–ALK fusion is an alternate mechanism for ALK activation in neuroblastoma

Published:2022-04-11 Issue:20 Volume:41 Page:2789-2797
ISSN:0950-9232
Container-title:Oncogene
language:en
Short-container-title:Oncogene

Author:

Hiwatari Mitsuteru^ORCID,Seki Masafumi^ORCID,Matsuno Ryosuke^ORCID,Yoshida Kenichi^ORCID,Nagasawa Takeshi^ORCID,Sato-Otsubo Aiko^ORCID,Yamamoto Shohei^ORCID,Kato Motohiro^ORCID,Watanabe Kentaro^ORCID,Sekiguchi Masahiro^ORCID,Miyano Satoru^ORCID,Ogawa Seishi^ORCID,Takita Junko^ORCID

Funder

MEXT | Japan Society for the Promotion of Science

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Molecular Biology

Link

https://www.nature.com/articles/s41388-022-02301-1.pdf

Reference56 articles.

1. Maris JM. Recent advances in neuroblastoma. N Engl J Med. 2010;362:2202–11.

2. Mazzocco K, Defferrari R, Sementa AR, Garaventa A, Longo L, De Mariano M, et al. Genetic abnormalities in adolescents and young adults with neuroblastoma: a report from the Italian Neuroblastoma group. Pediatr Blood Cancer. 2015;62:1725–32.

3. Mossé YP, Deyell RJ, Berthold F, Nagakawara A, Ambros PF, Monclair T, et al. Neuroblastoma in older children, adolescents and young adults: a report from the International Neuroblastoma Risk Group project. Pediatr Blood Cancer. 2014;61:627–35.